Ryght AI, a Laguna Beach, CA-based provider of real-time generative AI solutions for the clinical research industry, has raised $3 million in seed funding.
Investors
The round was led by Foothill Ventures, with participation from AIX Ventures, Virtue Ventures, IASO Ventures, Top Harvest Capital, and Page One Ventures.
Foothill Ventures is a California-based seed-stage venture capital firm that invests in technically driven startups across software, deep tech, and life sciences. Known for its founder-friendly approach, the firm typically writes initial checks of around $1.5 million and focuses on supporting early-stage companies with strong technical teams.
Ryght Use of Funds
The company will use the funds to accelerate partnerships with academic medical centers and expand its AI-driven platform for clinical trial site identification, selection, and activation.
About Ryght AI
Founded in 2024, Ryght AI provides an agentic AI platform designed to automate every step of clinical trial site selection, activation, and enrollment. By combining generative AI agents with a secure digital-twin network of over 100,000 trial sites, SOC 2 compliance, and integrated applications for sponsors, CROs, and research sites, Ryght delivers “service as software” that accelerates trials, reduces costs, and improves patient access to new therapies. Headquartered in Laguna Beach, California, Ryght AI automates key stages of clinical trials—feasibility assessments, site selection, site activation, and patient enrollment.
Funding Details
Company: Ryght AI, Inc.
Raised: $3.0M
Round: Seed
Funding Date: June 2025
Lead Investor: Foothill Ventures
Additional Investors: AIX Ventures, Virtue Ventures, IASO Ventures, Top Harvest Capital, Page One Ventures
Website: https://www.ryght.ai/
Software Category: Clinical Research / Generative AI / HealthTech
Source: https://www.webwire.com/ViewPressRel.asp?aId=339681